Organization

Bleeding and Clotting Disorders Institute

1 clinical trial

Clinical trial
Emicizumab for Severe VON Willebrand Disease (VWD) and VWD/Hemophilia A
Status: Recruiting, Estimated PCD: 2025-11-01